PATENT CLAIM ANALYSIS

Application Number: 16358410
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

Claim (Index 69):
The method of  claim 42 , wherein the B-cell proliferative disorder is lymphoma, non-Hodgkins lymphoma (NHL), indolent NHL, aggressive NHL, relapsed aggressive NHL, relapsedindolent NHL, refractory NHL, refractory indolent NHL, chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, leukemia, hairy cell leukemia (HCL), acute lymphocytic leukemia (ALL), or mantle cell lymphoma.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.07143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13973669', '13760751', '15349964', '11754899', '14960015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7938846113512752
- 35 USC 102 Novelty (BERT): 0.592522523909198
- Combined Prediction Score: 0.7737484026070675
- Mean Citation Score: 451.129036
- Max Citation Score: 461.6173
- Similarity Product: 437.3401250216245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test